RAD51C and ovarian cancer: The currently identified RAD51C duplication was confirmed as the same chr17 c.-31512_965+1210dup{insCTTTTGTGAG} allele that has previously been reported in breast and ovarian cancer cases from a Southern Finnish cohort (6/2533, 0.2%) [17].